Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis
Crossref DOI link: https://doi.org/10.1186/s12885-016-2359-1
Published Online: 2016-05-24
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bazzi, Zainab A.
Lanoue, Danielle
El-Youssef, Mouhanned
Romagnuolo, Rocco
Tubman, Janice
Cavallo-Medved, Dora
Porter, Lisa A.
Boffa, Michael B.
Funding for this research was provided by:
Windsor Essex County Cancer Centre Foundation